| |
|
|
|
Millendo Therapeutics Inc.  
|
|
6.77 0.07 (0.01%) |
09-17 16:00 |
|
Open: |
6.7488 |
Pre close: |
6.7 |
Target:
|
8.76 
|
|
High: |
6.88 |
Low: |
6.62 |
Resistance:
|
7.50
8.76
|
|
Volume: |
23,590 |
Market Cap: |
91M |
Support:
|
5.68
4.56
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
6.29
 |
MACD |
MACD(12,26):
|
-0.54 |
|
MA(20): |
6.10 |
Signal(12,26,9): |
-0.83 |
|
MA(100): |
11.30 |
Stochastic Oscillator |
%K(14,3):
|
77.27 |
|
MA(250): |
11.45 |
%D(3): |
63.49 |
|
Average Volume(K) |
3-Month: |
5242
|
52-Week |
High:
|
17.34 |
|
10-Days: |
2968 |
Low: |
4.56 |
|
RSI |
RSI(14):
|
51.15 |
Change(%): |
-36.6 |
|
Financials, Statistics and Valuation |
|
EPS |
-4.860 |
Return on Equity (ttm) |
-124.3 |
Shares Out. (M) |
13.41 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-54.8 |
Shares Float (M) |
5.68 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
7.03 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
59.14 |
|
Forward EPS |
0.000 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
247 |
|
Book Value (p.s.) |
3.950 |
EBITDA (p.s.) |
-2.571 |
P/E |
-1.39 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.71 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-35.12 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-18.77 |
P/CF |
-2.58 |
|
|
|
|
|
|
